![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 18
Zeitschriftenartikel
Szymaszkiewicz, Agata; Wlodarczyk, Jakub; Wasilewski, Andrzej; Di Marzo, Vincenzo; Storr, Martin; Fichna, Jakub und Zielinska, Marta
(2020):
Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
In: Naunyn-Schmiedebergs Archives of Pharmacology, Bd. 393, Nr. 8: S. 1357-1364
Szymaszkiewicz, Agata; Storr, Martin; Fichna, Jakub und Zielinska, Marta
(2019):
Enkephalinase inhibitors, potential therapeutics for the future treatment of diarrhea predominant functional gastrointestinal disorders.
In: Neurogastroenterology and Motility, Bd. 31, Nr. 4, e13526
Fabisiak, Adam; Wlodarczyk, Marcin; Fabisiak, Natalia; Storr, Martin und Fichna, Jakub
(2019):
Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis.
In: Journal of Gastrointestinal and Liver Diseases, Bd. 28, Nr. 4
Szymaszkiewicz, Agata; Zielinska, Marta; Li, Kun; Ramanathan, Mani; Alam, Safiul; Hou, Duen-Ren; Fichna, Jakub und Storr, Martin
(2018):
Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice.
In: Naunyn-Schmiedebergs Archives of Pharmacology, Bd. 391, Nr. 4: S. 435-444
Binienda, Agata; Storr, Martin; Fichna, Jakub und Salaga, Maciej
(2018):
Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review.
In: Current Drug Targets, Bd. 19, Nr. 15: S. 1774-1781
Salaga, Maciej; Binienda, Agata; Tichkule, Ritesh B.; Thakur, Ganesh A.; Makriyannis, Alexandros; Storr, Martin und Fichna, Jakub
(2018):
The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome.
In: European Journal of Pharmacology, Bd. 836: S. 34-43
Wasilewski, Andrzej; Lewandowska, Urszula; Mosinska, Paula; Watala, Cezary; Storr, Martin; Fichna, Jakub und Venkatesan, Thangam
(2017):
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated With Cyclic Vomiting Syndrome.
In: American Journal of Gastroenterology, Bd. 112, Nr. 6: S. 933-939
Mosinska, Paula; Zatorski, Hubert; Storr, Martin und Fichna, Jakub
(2017):
Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists.
In: Journal of Neurogastroenterology and Motility, Bd. 23, Nr. 2: S. 171-179
[PDF, 706kB]
Fabisiak, Adam; Wlodarczyk, Jakub; Fabisiak, Natalia; Storr, Martin und Fichna, Jakub
(2017):
Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal.
In: Journal of Neurogastroenterology and Motility, Bd. 23, Nr. 3: S. 341-348
[PDF, 559kB]
Zielińska, Marta; Jarmuż, Agata; Salaga, Maciej; Kordek, Radzislaw; Laudon, Moshe; Storr, Martin und Fichna, Jakub
(2016):
Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice.
In: Naunyn-Schmiedebergs Archives of Pharmacology, Bd. 389, Nr. 5: S. 511-519
Mosińska, Paula; Socala, Katarzyna; Nieoczym, Dorota; Laudon, Moshe; Storr, Martin; Fichna, Jakub und Wlaz, Piotr
(2016):
Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice.
In: Behavioural Brain Research, Bd. 307: S. 199-207
Jarmuż, Agata; Zielińska, Marta; Len, Karolina; Banaszek, Martyna; Storr, Martin und Fichna, Jakub
(2016):
Review: The Role of MOP and DOP Receptors in Treatment of Diarrhea-predominant Irritable Bowel Syndrome.
In: Mini-Reviews in Medicinal Chemistry, Bd. 16, Nr. 18: S. 1462-1469
Salaga, Maciej; Storr, Martin; Martemyanov, Kirill A. und Fichna, Jakub
(2016):
akademischenFestredenEmilDuBois-Reymonds(1818–1896).
In: Bioessays, Bd. 38, Nr. 4: S. 344-354
Krohn, Regina M.; Parsons, Sean A.; Fichna, Jakub; Patel, Kamala D.; Yates, Robin M.; Sharkey, Keith A. und Storr, Martin A.
(2016):
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment.
In: Journal of inflammation
13:21
[PDF, 1MB]
Mosińska, Paula; Storr, Martin und Fichna, Jakub
(2015):
The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective.
In: Therapeutic Advances in Gastroenterology, Bd. 8, Nr. 5:
278 -284
[PDF, 104kB]
Fichna, Jakub; Bawa, Misha; Thakur, Ganesh A.; Tichkule, Ritesh; Makriyannis, Alexandros; McCafferty, Donna-Marie; Sharkey, Keith A. und Storr, Martin
(2014):
Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors.
In: PLOS ONE 9(10), e109115 [PDF, 1MB]
In: PLOS ONE 9(10), e109115 [PDF, 1MB]
Kaplan, Gilaad G.; Szyszkowicz, Mieczyslaw; Fichna, Jakub; Rowe, Brian H.; Porada, Eugeniusz; Vincent, Renaud; Madsen, Karen; Ghosh, Subrata und Storr, Martin
(2012):
Non-specific abdominal pain and air pollution: a novel association.
In: PLOS ONE 7(10), e47669 [PDF, 399kB]
In: PLOS ONE 7(10), e47669 [PDF, 399kB]
Fichna, Jakub und Storr, Martin A.
(2012):
Brain-gut interactions in IBS.
In: Frontiers in Pharmacology, Bd. 3, 127
[PDF, 649kB]